Quest Diagnostics Inc (DGX) insider trading.
In Q3 2026, insiders at Quest Diagnostics Inc reported 15 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $8.3M.
- Transactions
- 15
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -34,277
- Insiders
- 10
- Last filed
- 2026-09-03
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Prevoznik Michael E | Officer · SVP & General Counsel | 5 | 0 | 3 |
| Delaney Mark E | Officer · SVP & Chief Commercial Officer | 2 | 0 | 1 |
| Davis J. E. | Director, Officer · CEO and President | 1 | 0 | 1 |
| Lassiter Wright III | Director | 1 | 0 | 0 |
| Samad Sam | Officer · Executive Vice President & CFO | 1 | 0 | 0 |
| Main Timothy L | Director | 1 | 0 | 0 |
| Plewman Patrick | Officer · SVP for Diagnostic Services | 1 | 0 | 0 |
| Gregg Vicky B | Director | 1 | 0 | 0 |
| Carter Robert B | Director | 1 | 0 | 0 |
| Kuppusamy Karthik | Officer · SVP, Clinical Solutions | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Davis J. E. | S (D) | 10,000 | $242.72 | 122,423 | Form 4 |
| 2026-08-28 | Prevoznik Michael E | G (D) | 1,000 | $0 | 36,557 | Form 4 |
| 2026-08-28 | Prevoznik Michael E | S (D) | 430 | $244.51 | 37,557 | Form 4 |
| 2026-08-28 | Prevoznik Michael E | S (D) | 6,237 | $243.63 | 37,987 | Form 4 |
| 2026-08-28 | Prevoznik Michael E | S (D) | 16,010 | $242.88 | 44,224 | Form 4 |
| 2026-08-28 | Prevoznik Michael E | M (A) | 22,677 | $112.17 | 60,234 | Form 4 |
| 2026-07-28 | Delaney Mark E | S (D) | 1,600 | $235.18 | 10,335 | Form 4 |
| 2026-07-22 | Delaney Mark E | L (A) | 34 | $206.81 | 11,935 | Form 4 |
| 2026-07-22 | Lassiter Wright III | L (A) | 6 | $206.81 | 10,323 | Form 4 |
| 2026-07-22 | Samad Sam | A (A) | 102 | $206.81 | 33,478 | Form 4 |
| 2026-07-22 | Main Timothy L | L (A) | 21 | $206.81 | 22,460 | Form 4 |
| 2026-07-22 | Plewman Patrick | L (A) | 46 | $206.81 | 15,293 | Form 4 |
| 2026-07-22 | Gregg Vicky B | A (A) | 72 | $206.81 | 18,386 | Form 4 |
| 2026-07-22 | Carter Robert B | L (A) | 11 | $206.8 | 3,864 | Form 4 |
| 2026-07-22 | Kuppusamy Karthik | L (A) | 37 | $206.81 | 13,557 | Form 4 |
Transaction codes in this quarter
Get DGX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1022079&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · DGX company page · Quest Diagnostics Inc on SEC.gov
Questions
Are insiders buying or selling Quest Diagnostics Inc (DGX)?
In Q3 2026, insiders at Quest Diagnostics Inc reported 15 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $8.3M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Quest Diagnostics Inc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/dgx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.